Self-complementary adeno-associated virus serotype 2 vector: Global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

被引:130
|
作者
Fu, HY
Muenzer, J
Samulski, RJ
Breese, G
Sifford, J
Zeng, XH
McCarty, DM
机构
[1] Univ N Carolina, Gene Therapy Ctr, Sch Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA
关键词
D O I
10.1016/j.ymthe.2003.08.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The blood-brain barrier is the main obstacle to efficient delivery of therapeutic reagents, including viral vectors, into the central nervous system (CNS) for treating global CNS diseases. In this study, the effects of mannitol infusions on global brain gene expression of a novel AAV vector were examined after intravenous (iv) or intracisternal injection. Initially, a self-complementary adeno-associated virus serotype 2 vector (scAAV) was compared to traditional single-stranded AAV2 vector for reporter gene expression in the brain of adult mice with or without pretreatment of an iv mannitol infusion. One to two months postinjection, analysis of vector-transduced green fluorescent protein (GFP) expression in the brain revealed that vector delivery to the CNS via iv injection required pretreatment with mannitol. This expression was observed only when scAAV vectors were used. Using these conditions, transgene expression was observed in various neurons and glial cells throughout the brain. The peripherally administered scAAV vectors also transduced the cells in multiple somatic tissues with efficient expression in liver (20-30% of hepatocytes), but was less efficient in other somatic tissues. Intracisternal injection of scAAV vector produced a broad and intense transgene expression in both neurons and glial cells in the CNS of injected mice ranging from the olfactory area to the brain stem and spinal cord. More than 50% of the Purkinje cells in the cerebellum expressed GFP. Intravenous infusion of mannitol before intracisternal injection of the scAAV vector enhanced the dispersion of the vector in the CNS. Further optimization of these steps combining peripheral and intracisternal scAAV gene delivery should facilitate the development of treatments for global CNS diseases, especially diseases involving both the somatic system and the CNS, such as lysosomal storage disorders.
引用
收藏
页码:911 / 917
页数:7
相关论文
共 50 条
  • [41] Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
    Gray, Steven J.
    Foti, Stacey B.
    Schwartz, Joel W.
    Bachaboina, Lavanya
    Taylor-Blake, Bonnie
    Coleman, Jennifer
    Ehlers, Michael D.
    Zylka, Mark J.
    McCown, Thomas J.
    Samulski, R. Jude
    HUMAN GENE THERAPY, 2011, 22 (09) : 1143 - 1153
  • [42] Gene Delivery of Vasostatin via a Self-Complementary Adeno-Associated Virus 2 Inhibits Ocular Neovascularization in Rats
    Tu, Leilei
    Wang, Jiang-Hui
    Prea, Selwyn M.
    Tai, Ming-Hong
    Bui, Bang V.
    Dusting, Gregory J.
    Liu, Guei-Sheung
    MOLECULAR THERAPY, 2017, 25 (05) : 201 - 201
  • [43] Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease
    Karumuthil-Melethil, Subha
    Kalburgi, Sahana Nagabhushan
    Thompson, Patrick
    Tropak, Michael
    Kaytor, Michael D.
    Keimel, John G.
    Mark, Brian L.
    Mahuran, Don
    Walia, Jagdeep S.
    Gray, Steven J.
    HUMAN GENE THERAPY, 2016, 27 (07) : 509 - 521
  • [44] Self-complementary AAV5 vector facilitates quicker transgene expression in photoreceptor and retinal pigment epithelial cells of normal mouse
    Kong, Fansheng
    Li, Wensheng
    Li, Xia
    Zheng, Qinxiang
    Dai, Xufeng
    Zhou, Xiangtian
    Boye, Sanford L.
    Hauswirth, William W.
    Qu, Jia
    Pang, Ji-Jing
    EXPERIMENTAL EYE RESEARCH, 2010, 90 (05) : 546 - 554
  • [45] A new, non-imunogenic gene therapy vector for the human trabecular meshwork: scAAV (self-complementary adeno-associated virus)
    Li, G
    Choi, V
    Bryant, PA
    Samulski, RJ
    Borras, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [46] Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
    Qing, KY
    Wang, XS
    Kube, DM
    Ponnazhagan, S
    Bajpai, A
    Srivastava, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10879 - 10884
  • [47] Safety Study of Adeno-Associated Virus Serotype 2-Mediated Human Acid Sphingomyelinase Expression in the Nonhuman Primate Brain
    Salegio, Ernesto A.
    Samaranch, Lluis
    Jenkins, Russell W.
    Clarke, Christopher J.
    Lamarre, Clementine
    Beyer, Janine
    Kells, Adrian P.
    Bringas, John
    San Sebastian, Waldy
    Richardson, R. Mark
    Rosenbluth, Kate H.
    Hannun, Yusuf A.
    Bankiewicz, Krystof S.
    Forsayeth, John
    HUMAN GENE THERAPY, 2012, 23 (08) : 891 - 902
  • [48] Single-polarity recombinant adeno-associated virus 2 vector-mediated transgene expression in vitro and in vivo:: Mechanism of transduction
    Zhong, Li
    Zhou, Xiaohuai
    Li, Yanjun
    Qing, Keyun
    Xiao, Xiao
    Samulski, Richard Jude
    Srivastava, Arun
    MOLECULAR THERAPY, 2008, 16 (02) : 290 - 295
  • [49] Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2
    Veron, Philippe
    Allo, Valerie
    Riviere, Christel
    Bernard, Jacky
    Douar, Anne-Marie
    Masurier, Carole
    JOURNAL OF VIROLOGY, 2007, 81 (10) : 5385 - 5394
  • [50] Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo:: a comparative study with adenovirus vectors
    Vassalli, G
    Büeler, H
    Dudler, J
    von Segesser, LK
    Kappenberger, L
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 90 (2-3) : 229 - 238